Diversity, Equity, and Inclusion Are Crucial in Pharmacy

Pharmacy Practice in Focus: Health SystemsMarch 2023
Volume 12
Issue 2

Pharmacy Times® commits to incorporating DEI concepts into our coverage and focusing on social determinants of health (SDOH).

Pharmacy Times: Call for Papers

Pharmacy Times Oncology EditionTM and Pharmacy Times Health-System EditionTM are seeking to expand our current coverage offerings to include peer reviewed research on clinical topics and treatment of different disease states.

The publications are seeking to focus on a wide range of therapeutic categories in the oncology and health-system pharmacy space to educate readers and translate innovative clinical discoveries into improved health outcomes for patients. This new focus on clinical research seeks to accelerate adaptation of new therapeutics, techniques, and technologies from the publication’s pages to the clinical setting.

The clinical manuscripts sought will examine different treatments for and management of the different disease states and pharmacologic interventions. Of particular interest are papers that highlight the role of the pharmacist within the overall health care team and provide insight into the impact pharmacists have on patient outcomes. These submissions will be peer-reviewed and published in upcoming editions of Pharmacy Times Oncology Edition and Pharmacy Times Health-System Edition.

Some clinical topics of interest include:

  • Transitions of Care
  • Immuno-oncology
  • Hematology
  • Breast Cancer
  • Lung Cancer
  • Leukemia/Lymphoma
  • Ovarian Cancer
  • Melanoma
  • Head and Neck Cancer
  • Antimicrobial Stewardship
  • Cardiovascular Disease
  • Renal Disease
  • Metabolic Disease
  • 340B
  • Biosimilar Adoption
  • Immunizations
  • HIV and Pre-exposure Prophylaxis

To send in research paper submissions or if you have any questions, please email Davy James (djames@pharmacytimes.com) or Alana Hippensteele (ahippensteele@mjhlifesciences.com). 

Seven pharmacy organizations released a statement on February 3, 2023, outlining their commitment to diversity, equity, and inclusion (DEI) in the profession.1

The organizations are the American Association of Colleges of Pharmacy, the American Pharmacists Association, the American Pharmacists Association-Academy of Student Pharmacists, the American Society of Health-System Pharmacists, BHK Consulting LLC, the National Association of Boards of Pharmacy, and the National Pharmaceutical Association.1

In the statement, the organizations outlined 8 steps they plan to undertake, including implementing and supporting policies and programs that eliminate financial barriers for individuals of color who seek health care professional opportunities such as pursuing degrees, incorporating DEI concepts into health care curricula and continuing education requirements, and developing mentorship opportunities for individuals of color who are students or new professionals.1

Pharmacy Times® commits to incorporating DEI concepts into our coverage and focusing on social determinants of health (SDOH). In February, we celebrated Black History Month with a series of articles and videos on Pharma cyTimes.com, and we will focus on important topics related to DEI and SDOH going forward.

In other news, in his State of the Union address on February 7, 2023, President Joseph R. Biden took aim at pharmaceutical companies over drug pricing but did not mention pharmacy benefit managers (PBMs).2 In his comments, the president discussed the recent $35 cap on insulin prices for seniors on Medicare and urged lawmakers to cap the hormone at $35 a month for all Americans. Biden also discussed potential caps for oncology drugs.2 The address also touched on other key health concerns, such as accessibility and COVID-19.2

The National Association of Chain Drug Stores published a response to the address on its website on February 8, 2023, saying the government should do more to rein in PBMs.3

Pharmacy Times® will continue to report on the issue of drug pricing and the role played by PBMs in drug pricing and ensurin g that patients have access to needed medications.

In this issue, we look at other important topics, such as home infusions, long-acting injectables to treat HIV, and the next generation of PARP inhibitors. Our Cover Feature takes a deep dive into pharmacogenomics. We hope you find this coverage valuable.

Thanks for reading!


1. APhA, national organizations release statement on ensuring diversity, equity, and inclusion in health care. News release. American Pharmacists Association. February 3, 2023. Accessed February 13, 2023. https://pharmacist.com/APhA-Press-Releases/apha-national-organizations-release-statement-on-ensuring-diversity-equity-and-inclusion-in-health-care

2. Wolf ZB, Merrill C. Biden’s State of the Union address annotated and fact-checked. CNN. February 8, 2023. Accessed February 8, 2023. https://www.cnn.com/interactive/2023/02/annotated-fact-checked-president-biden-sotu/

3. NACDS statement in response to State of the Union address. National Association of Chain Drug Stores. February 8, 2023. Accessed February 10, 2023. https://www.nacds.org/news/nacds-statement-in-response-to-state-of-the-union-address/

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.